2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$518.20+$5.32 (+1.04%)
Price as of Aug 25, 2026 1:41 PM EDT- $22.0BMarket Cap
- 67.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$518.20+$5.32 (+1.04%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $512.88 | ||
Change | -$0.24 (-0.05%) | ||
Open | $513.12 | ||
High | $514.29 | ||
Low | $508.15 | ||
Previous Close | $513.12 | ||
Volume | 323,875 | ||
30-Day Average Volume | 525,992 | ||
1-Week Change | 0.87% | ||
1-Month Change | -2.95% | ||
1-Year Change | 67.95% | ||
3-Year Change | 122.48% | ||
5-Year Change | 149.52% | ||
Fundamentals | |||
Shares Outstanding | 42.9M | ||
Total Assets | $7.2B | ||
Market Cap | $22.0B | ||
Enterprise Value | $20.4B | ||
Period: QTR TTM FY | |||
Revenue | $783.3M | ||
Net Income | $333.0M | ||
Free Cash Flow | $205.6M | ||
EBIT | $372.7M | ||
EBITDA | $396.9M | ||
Net Working Capital | $2.9B | ||
EPS | $7.27 | ||
Enterprise Value/EBITDA | 51 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 3 | ||
P/E | 71 | ||
PEG | 3 | ||
Price/Free Cash Flow | 107 | ||
Price/Operating Cash Flow | 70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue